This further suggests that PI3K pathway alterations are a frequent molecular event in TNBC and that the respective contributions of RICTOR, PIK3CA, and PTEN to mTOR hyperactivation may drive tumor progression. The gene discussed is RICTOR; the disease is neoplasm.